Increasing life expectancy has led to silently progressive neurodegenerative disorders becoming more prominent worldwide. In the case of neurodegenerative disorders like Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease, the urgent need for targeted and effective treatments is more significant than ever.
Major technological advancements have spurred research and development in the biotechnology industry, leading to the discovery of novel therapeutic platforms that can target the root cause of diseases.
With the help of advanced technologies such as artificial intelligence, gene editing, and precision medicine, biotech companies are now better equipped to develop new treatment strategies. One promising approach gaining significant attention in recent years involves targeting the overactive immune system and reducing systemic inflammation to mitigate the detrimental effects of neuroinflammation.
Yet another year is coming to a close, marking another groundbreaking year in medicine. 2021 continued to test the healthcare system and its dedicated professionals with COVID-19 surges and viral variants, rising cases of chronic disease, and nationwide health crises demanding immediate attention.
In line with the A4M mission to disseminate the latest knowledge in modern medicine, we strive to keep clinicians up to date and well-equipped to tackle any clinical challenge with our weekly blog articles. From the role of hormonal health in immunocompetence to the latest successes in Alzheimer’s disease therapeutics, topics featured on the A4M blog highlight essential developments in the industry. To wrap up the year, we compiled a list of our readers’ favorite blogs from 2021.
The month of June observes Alzheimer’s and Brain Awareness Month recognizing the over 50 million people living with Alzheimer’s disease (AD) and other forms of dementia worldwide. Organizers of the campaign work to ameliorate a global lack of understanding of neurodegenerative diseases; they strive to inform, educate, and provide support for dementia sufferers and their loved ones.
A growing body of research has been able to identify several factors that may contribute to the development of the condition. Diabetes, hypertension, obesity, depression, cognitive inactivity, and other modifiable risk factors have all been associated with dementia, while many others are under investigation.